"It's not any different than hypertension or diabetes or the many other chronic illnesses that we deal with, where you have to use chronic medication." For over the past three years, the arrival of a new class of drugs known as GLP-1 agonists, so-called for their ability to mimic the action of the natural GLP-1 gut hormone that promotes satiety, has transformed the weight-loss field
What clinical evidence supports using semaglutide long-term
Proven Efficacy: Clinical trials have shown that high-dose oral semaglutide produces weight loss results comparable to the injectable versions
Medications like GLP-1 agonists are referred to as incretin mimetics since they mimic these effects
Pregnancy plans or breastfeeding status , as Ozempic is not recommended during pregnancy or lactation
For this latest analysis, researchers explored real-world data from more than 90,000 HFpEF patients with obesity and type 2 diabetes who received treatment from 2018 to 2024